Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria

    JAMA Date published:

  • Inhaled Ciclesonide for Community-Based COVID -19: A Placebo-Controlled Randomised Trial

    Respirology Date published:

  • Patterns of follow-up testing of abnormal eGFR and UACR for the detection of chronic kidney disease in Australian primary care: analysis of a national general practice dataset

    BMJ Open Date published:

  • Glomerular Disease Registry and Biobank: Baseline and Follow-Up Results

    Journal of the American Society of Nephrology Date published:

  • Predictive Value of Established and Novel Biomarkers for Kidney Outcomes in CKD: A Comparative Validation Study

    Journal of the American Society of Nephrology Date published:

  • Variability in eGFR and Adverse Kidney Outcomes in Routine Clinical Practice

    Journal of the American Society of Nephrology Date published:

  • Incidence of CKD in Australian Primary Care: Analysis of a National Primary Care Dataset

    Journal of the American Society of Nephrology Date published:

  • Renin-Angiotensin System Inhibitor (RASi) Use and Atrasentan in IgAN: Post Hoc Analysis from the ALIGN Trial

    Journal of the American Society of Nephrology Date published:

  • Patients’ Perspectives on Living With Primary Membranous Nephropathy: A Semi-Structured Interview Study

    American Journal of Kidney Diseases Date published:

  • Changing paradigms of studies in kidney diseases

    Kidney International Date published:

  • Sex Differences Across Corticosteroid Response and Outcomes in IgA Nephropathy

    Kidney International Reports Date published:

  • Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial

    The Lancet Date published:

  • Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset

    Diabetes, Obesity and Metabolism Date published:

  • SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome Trials

    Clinical Journal of the American Society of Nephrology Date published:

  • Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Kidney International Date published:

  • Corticosteroid Effects in IgA Nephropathy by Baseline Proteinuria and Estimated GFR

    Kidney International Reports Date published: